2023
ACR–ARS Practice Parameter for the Performance of Total Body Irradiation
Reilly M, Dandapani S, Kumar K, Constine L, Fogh S, Roberts K, Small W, Schechter N. ACR–ARS Practice Parameter for the Performance of Total Body Irradiation. American Journal Of Clinical Oncology 2023, 46: 185-192. PMID: 36907934, DOI: 10.1097/coc.0000000000000997.Peer-Reviewed Original ResearchConceptsTotal body irradiationConventional total body irradiationBody irradiationPractice parametersAmerican Radium SocietyHigh-dose total body irradiationMean lung doseLung doseAmerican CollegeRadiation oncologistsClinical interestRadiation oncologyDose inhomogeneityACR websiteRadiation therapistsComprehensive updateTreatment planning systemOncologyPatient setupRotational techniqueAverage dose rateDose rateOngoing investigationOncologistsMedical physicists
1999
Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia
Jillella A, Doria R, Khan K, Zelterman D, Ahmad Y, Smith B, Holmes W, Becker P, Roberts K, Rappeport J. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia. Bone Marrow Transplantation 1999, 23: 1095-1100. PMID: 10382947, DOI: 10.1038/sj.bmt.1701786.Peer-Reviewed Original ResearchConceptsAllogeneic bone marrow transplantationTotal body irradiationBone marrow transplantationConditioning regimenMarrow transplantationMyeloablative regimenRelapse rateBody irradiationHematologic malignanciesAntileukemic effectGood prognosis diseaseHigh-dose cytosineHost disease (GVHD) prophylaxisShort-course methotrexateEvidence of diseaseOverall relapse rateHigh-dose AraPoor prognosis diseaseKaplan-Meier estimatesActuarial survivalConditioning regimensDisease prophylaxisMyeloablative regimensProspective studyRegimen